科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/06/16 | 3,602 | 3,682 | 3,601 | 3,681 | +80 | +2.2% | 249,000 |
| 2023/06/15 | 3,615 | 3,618 | 3,601 | 3,601 | -19 | -0.5% | 76,400 |
| 2023/06/14 | 3,667 | 3,667 | 3,616 | 3,620 | -24 | -0.7% | 78,700 |
| 2023/06/13 | 3,676 | 3,676 | 3,635 | 3,644 | -28 | -0.8% | 80,300 |
| 2023/06/12 | 3,691 | 3,715 | 3,662 | 3,672 | +3 | +0.1% | 92,800 |
| 2023/06/09 | 3,679 | 3,687 | 3,655 | 3,669 | +50 | +1.4% | 168,000 |
| 2023/06/08 | 3,633 | 3,653 | 3,594 | 3,619 | -13 | -0.4% | 91,200 |
| 2023/06/07 | 3,660 | 3,686 | 3,628 | 3,632 | -18 | -0.5% | 101,800 |
| 2023/06/06 | 3,628 | 3,658 | 3,598 | 3,650 | +22 | +0.6% | 84,300 |
| 2023/06/05 | 3,639 | 3,671 | 3,618 | 3,628 | +43 | +1.2% | 127,300 |
| 2023/06/02 | 3,520 | 3,585 | 3,520 | 3,585 | +85 | +2.4% | 91,300 |
| 2023/06/01 | 3,515 | 3,520 | 3,490 | 3,500 | ±0 | ±0% | 146,000 |
| 2023/05/31 | 3,535 | 3,545 | 3,485 | 3,500 | -60 | -1.7% | 198,500 |
| 2023/05/30 | 3,580 | 3,590 | 3,535 | 3,560 | -25 | -0.7% | 110,200 |
| 2023/05/29 | 3,620 | 3,620 | 3,585 | 3,585 | -10 | -0.3% | 61,500 |
| 2023/05/26 | 3,640 | 3,640 | 3,595 | 3,595 | -35 | -1% | 104,200 |
| 2023/05/25 | 3,655 | 3,680 | 3,630 | 3,630 | -35 | -1% | 95,900 |
| 2023/05/24 | 3,660 | 3,670 | 3,650 | 3,665 | -15 | -0.4% | 75,900 |
| 2023/05/23 | 3,735 | 3,745 | 3,660 | 3,680 | -35 | -0.9% | 108,900 |
| 2023/05/22 | 3,705 | 3,730 | 3,680 | 3,715 | +10 | +0.3% | 69,000 |
| 2023/05/19 | 3,700 | 3,740 | 3,685 | 3,705 | +5 | +0.1% | 72,400 |
| 2023/05/18 | 3,780 | 3,780 | 3,695 | 3,700 | -80 | -2.1% | 95,700 |
| 2023/05/17 | 3,785 | 3,810 | 3,770 | 3,780 | -10 | -0.3% | 77,600 |
| 2023/05/16 | 3,710 | 3,790 | 3,710 | 3,790 | +100 | +2.7% | 81,800 |
| 2023/05/15 | 3,690 | 3,705 | 3,660 | 3,690 | +45 | +1.2% | 75,200 |
| 2023/05/12 | 3,630 | 3,660 | 3,620 | 3,645 | +5 | +0.1% | 119,700 |
| 2023/05/11 | 3,720 | 3,750 | 3,635 | 3,640 | -155 | -4.1% | 178,800 |
| 2023/05/10 | 3,850 | 3,890 | 3,780 | 3,795 | -25 | -0.7% | 191,100 |
| 2023/05/09 | 3,800 | 3,830 | 3,795 | 3,820 | +10 | +0.3% | 63,800 |
| 2023/05/08 | 3,770 | 3,845 | 3,770 | 3,810 | +25 | +0.7% | 62,200 |
| 2023/05/02 | 3,840 | 3,840 | 3,785 | 3,785 | -35 | -0.9% | 69,700 |
| 2023/05/01 | 3,775 | 3,830 | 3,755 | 3,820 | +85 | +2.3% | 89,800 |
| 2023/04/28 | 3,745 | 3,760 | 3,735 | 3,735 | +35 | +0.9% | 93,800 |
| 2023/04/27 | 3,700 | 3,710 | 3,685 | 3,700 | -15 | -0.4% | 66,900 |
| 2023/04/26 | 3,735 | 3,735 | 3,700 | 3,715 | -20 | -0.5% | 53,700 |
| 2023/04/25 | 3,730 | 3,765 | 3,720 | 3,735 | +15 | +0.4% | 62,900 |
| 2023/04/24 | 3,745 | 3,765 | 3,710 | 3,720 | -5 | -0.1% | 54,200 |
| 2023/04/21 | 3,700 | 3,730 | 3,700 | 3,725 | +15 | +0.4% | 53,500 |
| 2023/04/20 | 3,700 | 3,735 | 3,690 | 3,710 | +10 | +0.3% | 47,700 |
| 2023/04/19 | 3,690 | 3,705 | 3,685 | 3,700 | ±0 | ±0% | 52,900 |
| 2023/04/18 | 3,710 | 3,720 | 3,690 | 3,700 | +5 | +0.1% | 65,800 |
| 2023/04/17 | 3,710 | 3,710 | 3,690 | 3,695 | -15 | -0.4% | 53,000 |
| 2023/04/14 | 3,715 | 3,735 | 3,700 | 3,710 | +10 | +0.3% | 92,000 |
| 2023/04/13 | 3,700 | 3,715 | 3,690 | 3,700 | +10 | +0.3% | 49,200 |
| 2023/04/12 | 3,680 | 3,700 | 3,660 | 3,690 | +25 | +0.7% | 92,900 |
| 2023/04/11 | 3,720 | 3,720 | 3,665 | 3,665 | -15 | -0.4% | 42,400 |
| 2023/04/10 | 3,675 | 3,685 | 3,660 | 3,680 | +30 | +0.8% | 36,600 |
| 2023/04/07 | 3,675 | 3,695 | 3,650 | 3,650 | -10 | -0.3% | 41,400 |
| 2023/04/06 | 3,635 | 3,675 | 3,620 | 3,660 | +30 | +0.8% | 87,900 |
| 2023/04/05 | 3,705 | 3,705 | 3,630 | 3,630 | -90 | -2.4% | 94,500 |
501～
550
件表示中 / 3733件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 376,400円 | -6.4% | -71.8% | 5.05% | 42.04倍 | 0.94倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| キッセイ薬 | 404,000円 | +3.6% | +6.1% | 2.97% | 13.61倍 | 0.80倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
ＪＴ傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がＴＯＢ実施 |
| ジーエヌアイ | 313,500円 | +21.7% | +999.9% | 0.00% | 13.14倍 | 4.35倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| サンバイオ | 217,400円 | - | - | 0.00% | - | 100.69倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
